Sera Prognostics, Inc.
Sera Prognostics, Inc. (SERA) Financial Performance & Income Statement Overview
Review Sera Prognostics, Inc. (SERA) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Sera Prognostics, Inc. (SERA) Income Statement & Financial Overview
Explore comprehensive income reports for Sera Prognostics, Inc. SERA, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $38000.00 | $24000.00 | $29000.00 | $24000.00 |
| Cost of Revenue | $40000.00 | $32000.00 | $13000.00 | $20000.00 |
| Gross Profit | -$2000.00 | -$8000.00 | $16000.00 | $4000.00 |
| Gross Profit Ratio | -$0.05 | -$0.33 | $0.55 | $0.17 |
| R&D Expenses | $3.33M | $3.14M | $3.50M | $4.41M |
| SG&A Expenses | $5.91M | $6.28M | $5.38M | $4.85M |
| Operating Expenses | $9.25M | $9.41M | $8.88M | $9.26M |
| Total Costs & Expenses | $9.29M | $9.45M | $8.89M | $9.28M |
| Interest Income | $0.00 | $673000.00 | $733000.00 | $671000.00 |
| Interest Expense | -$4000.00 | $6000.00 | $5000.00 | $8000.00 |
| Depreciation & Amortization | $0.00 | $211000.00 | $201000.00 | $208000.00 |
| EBITDA | -$9.25M | -$8.36M | -$7.71M | -$8.09M |
| EBITDA Ratio | -$243.42 | -$348.42 | -$265.97 | -$336.96 |
| Operating Income | -$9.25M | -$9.42M | -$8.86M | -$9.25M |
| Operating Income Ratio | -$243.42 | -$392.63 | -$305.59 | -$385.54 |
| Other Income/Expenses (Net) | $1.06M | $844000.00 | $943000.00 | $950000.00 |
| Income Before Tax | -$8.19M | -$8.58M | -$7.92M | -$8.30M |
| Income Before Tax Ratio | -$215.45 | -$357.46 | -$273.07 | -$345.96 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$8.19M | -$8.58M | -$7.92M | -$8.30M |
| Net Income Ratio | -$215.45 | -$357.46 | -$273.07 | -$345.96 |
| EPS | -$0.20 | -$0.25 | -$0.24 | -$0.25 |
| Diluted EPS | -$0.20 | -$0.25 | -$0.24 | -$0.25 |
| Weighted Avg Shares Outstanding | $41.97M | $33.94M | $33.52M | $32.93M |
| Weighted Avg Shares Outstanding (Diluted) | $41.97M | $33.94M | $33.52M | $32.93M |
The company's financials show resilient growth, with revenue advancing from $24000.00 in Q2 2024 to $38000.00 in Q1 2025. Gross profit remained healthy with margins at -5% in Q1 2025 compared to 17% in Q2 2024. Operating income hit -$9.25M last quarter, sustaining a consistent -24342% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$9.25M. Net income rose to -$8.19M, while earnings per share reached -$0.20. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan